Teva Pharmaceutical Industries LimitedTEVANYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank79
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P79
Within normal range
vs 2Y Ago
4.8x
Strong expansion
Streak
4 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 7.32% |
| 2024 | 5.83% |
| 2023 | 1.54% |
| 2022 | -2.35% |
| 2021 | -3.90% |
| 2020 | -3.55% |
| 2019 | -9.68% |
| 2018 | -15.48% |
| 2017 | -2.16% |
| 2016 | 8.03% |